Skip to content

BDSX

BIODESIX INC

NASDAQ · Healthcare · Medical - Diagnostics & Research · US

$29.20
+1.35%
Ask drillr
3
Insider buys (3m)
0
Insider sells (3m)
$1.0M
Net value (3m)
+68.7%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 13, 2026SCHULER JACK W · 10 percent owner, other: Emeritus DirectorPurchase15,000$24
Aug 12, 2026SCHULER JACK W · 10 percent owner, other: Emeritus DirectorPurchase13,900$24
Aug 12, 2026SCHULER JACK W · 10 percent owner, other: Emeritus DirectorPurchase13,700$24
Jul 2, 2026PATIENCE JOHN · director, other: ChairmanM-Exempt1,361$0.00
Apr 2, 2026PATIENCE JOHN · director, other: ChairmanM-Exempt1,361$0.00
Feb 23, 2026Cowie Robin Harper · officer: CFO, Sec'y & TreasurerSale535$13
Feb 23, 2026Pestano Gary Anthony · officer: Chief Development OfficerM-Exempt1,528$0.00
Feb 23, 2026O'Kane Kieran · officer: Chief Commercial OfficerSale535$13
Feb 23, 2026Vazquez Chris · officer: Chief Accounting OfficerSale211$13
Feb 23, 2026Hutton Scott · director, officer: President & CEOM-Exempt4,844$0.00
Feb 23, 2026O'Kane Kieran · officer: Chief Commercial OfficerM-Exempt1,469$0.00
Feb 23, 2026Cowie Robin Harper · officer: CFO, Sec'y & TreasurerM-Exempt1,469$0.00
Feb 23, 2026Hutton Scott · director, officer: President & CEOSale1,490$13
Feb 23, 2026Pestano Gary Anthony · officer: Chief Development OfficerSale556$13
Feb 23, 2026Vazquez Chris · officer: Chief Accounting OfficerM-Exempt563$0.00
Feb 11, 2026Cowie Robin Harper · officer: CFO, Sec'y & TreasurerM-Exempt2,427$0.00
Feb 11, 2026Vazquez Chris · officer: Chief Accounting OfficerM-Exempt235$0.00
Feb 11, 2026Pestano Gary Anthony · officer: Chief Development OfficerSale540$10
Feb 11, 2026Cowie Robin Harper · officer: CFO, Sec'y & TreasurerM-Exempt2,584$0.00
Feb 11, 2026Vazquez Chris · officer: Chief Accounting OfficerSale101$10
Feb 11, 2026Hutton Scott · director, officer: President & CEOM-Exempt610$0.00
Feb 11, 2026Pestano Gary Anthony · officer: Chief Development OfficerM-Exempt1,481$0.00
Feb 11, 2026O'Kane Kieran · officer: Chief Commercial OfficerSale584$10
Feb 11, 2026O'Kane Kieran · officer: Chief Commercial OfficerM-Exempt1,600$0.00
Feb 11, 2026Hutton Scott · director, officer: President & CEOM-Exempt9,388$0.00
Feb 11, 2026Hutton Scott · director, officer: President & CEOSale3,559$10
Feb 11, 2026Vazquez Chris · officer: Chief Accounting OfficerM-Exempt263$0.00
Feb 11, 2026Pestano Gary Anthony · officer: Chief Development OfficerM-Exempt68$0.00
Feb 11, 2026Pestano Gary Anthony · officer: Chief Development OfficerM-Exempt1,413$0.00
Feb 11, 2026O'Kane Kieran · officer: Chief Commercial OfficerM-Exempt1,527$0.00
Institutional positioning

13F filings over the trailing two quarters

New 34Increased 22Reduced 15Sold out 5
FilerActionSharesFiled
AIGH CAPITAL MANAGEMENT LLCNew Position758,328Apr 30, 2026
AIGH Capital Management LLCReduced678,328Aug 7, 2026
Soleus Capital Management, L.P.Increased585,958Aug 11, 2026
TELEMARK ASSET MANAGEMENT, LLCIncreased489,824May 12, 2026
Telemark Asset Management, LLCUnchanged489,824Aug 10, 2026
ABRDN PLCIncreased458,438Apr 29, 2026
SOLEUS CAPITAL MANAGEMENT, L.P.New Position416,599May 14, 2026
Aberdeen Group plcReduced388,639Jul 31, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased284,169Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position255,161May 15, 2026
ESSEX INVESTMENT MANAGEMENT CO LLCIncreased241,915Aug 6, 2026
OPALEYE MANAGEMENT INC.New Position238,047May 15, 2026
Opaleye Management Inc.Reduced180,000Aug 14, 2026
MARSHALL WACE, LLPNew Position141,636May 15, 2026
ESSEX INVESTMENT MANAGEMENT CO LLCNew Position132,086May 11, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 13, 2026